Table of Contents
ISRN Hepatology
Volume 2013, Article ID 174608, 8 pages
http://dx.doi.org/10.1155/2013/174608
Clinical Study

Selective Arterial Embolization of Liver Metastases from Gastrinomas: A Single-Centre Experience

1Department of Surgery, Academic Medical Center, Meibergdreef 9, P.O. Box 22660, 1105 AZ Amsterdam, The Netherlands
2Department of Medical Oncology, Academic Medical Center, Meibergdreef 9, P.O. Box 22660, 1105 AZ Amsterdam, The Netherlands
3Department of Intervention Radiology, Academic Medical Center, Meibergdreef 9, P.O. Box 22660, 1105 AZ Amsterdam, The Netherlands

Received 22 May 2013; Accepted 7 July 2013

Academic Editors: A. Granito and H. Malik

Copyright © 2013 Anneke P. J. Jilesen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. M. Zollinger and E. H. Ellison, “Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas,” Annals of Surgery, vol. 142, pp. 709–723, 1955. View at Google Scholar
  2. R. T. Jensen, B. Niederle, and E. Mitry, “Frascati consensus conference, European neuroendocrine tumor society, gastrinoma (duodenal and pancreatic),” Neuroendocrinology, vol. 84, no. 3, pp. 173–182, 2006. View at Google Scholar
  3. R. T. Jensen, G. Cadiot, M. L. Brandi et al., “ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes,” Neuroendocrinology, vol. 95, no. 2, pp. 98–119, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Rindi, G. Klöppel, H. Alhman et al., “TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system,” Virchows Archiv, vol. 449, no. 4, pp. 395–401, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Komminoth, A. Perren, K. Oberg, G. Rindi, G. Kloppel, and P. U. Heitz, “Gastrinoma,” in Pathology and Genetics: Tumors of the Endocrine Organs, R. A. DeLellis, R. Lloyd, P. U. Heitz, and C. Eng, Eds., pp. 191–194, WHO Classification of Tumors, IARC Press, Lyon, France, 2004. View at Google Scholar
  6. H. C. Weber, D. J. Venzon, J.-T. Lin et al., “Determinants of metastatic rate and survival in patients with Zollinger- Ellison syndrome: a prospective long-term study,” Gastroenterology, vol. 108, no. 6, pp. 1637–1649, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. J. R. Strosberg, A. Cheema, and L. K. Kvols, “A review of systemic and liver-directed therapies for metastatic neuroendocrine tumors of the gastroenteropancreatic tract,” Cancer Control, vol. 18, no. 2, pp. 127–137, 2011. View at Google Scholar · View at Scopus
  8. R. P. Riemsma, M. M. Bala, R. Wolff, and J. Kleijnen, “Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases,” The Cochrane Database of Systematic Reviews, no. 9, Article ID CD009498, 2012. View at Publisher · View at Google Scholar
  9. S. Dhand and R. Gupta, “Hepatic transcatheter arterial chemoembolization complicated by postembolization syndrome,” Seminars in Interventional Radiology, vol. 28, no. 2, pp. 207–211, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Yinglu, L. Changquan, Z. Xiaofeng, L. Bai, Z. Dezeng, and C. Zhe, “A new way: alleviating postembolization syndrome following transcatheter arterial chemoembolization,” Journal of Alternative and Complementary Medicine, vol. 15, no. 2, pp. 175–181, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. E. A. Eisenhauer, P. Therasse, J. Bogaerts et al., “New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1),” European Journal of Cancer, vol. 45, no. 2, pp. 228–247, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. J. Atema, R. Amri, O. R. Busch, E. A. Rauws, D. J. Gouma, and E. J. Nieveen van Dijkum, “Surgical treatment of gastrinomas: a single-centre experience,” HPB, vol. 14, no. 12, pp. 833–838, 2012. View at Google Scholar
  13. T. Sato, K. Konishi, H. Kimura et al., “Strategy for pancreatic endocrine tumors,” Hepato-Gastroenterology, vol. 47, no. 32, pp. 537–539, 2000. View at Google Scholar · View at Scopus
  14. H. A. Mitty, R. R. P. Warner, L. H. Newman, J. S. Train, and I. H. Parnes, “Control of carcinoid syndrome with hepatic artery embolization,” Radiology, vol. 155, no. 3, pp. 623–626, 1985. View at Google Scholar · View at Scopus
  15. P. P. Kamat, S. Gupta, J. E. Ensor et al., “Hepatic arterial embolization and chemoembolization in the management of patients with large-volume liver metastases,” CardioVascular and Interventional Radiology, vol. 31, no. 2, pp. 299–307, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. J. R. Strosberg, J. Choi, A. B. Cantor, and L. K. Kvols, “Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors,” Cancer Control, vol. 13, no. 1, pp. 72–78, 2006. View at Google Scholar · View at Scopus
  17. V. Meij, J. M. Zuetenhorst, R. van Hillegersberg et al., “Local treatment in unresectable hepatic metastases of carcinoid tumors: experiences with hepatic artery embolization and radiofrequency ablation,” World Journal of Surgical Oncology, vol. 3, article 75, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. R. S. Chamberlain, D. Canes, K. T. Brown et al., “Hepatic neuroendocrine metastases: does intervention alter outcomes?” Journal of the American College of Surgeons, vol. 190, no. 4, pp. 432–445, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. R. G. Marlink, J. J. Lokich, J. R. Robins, and M. E. Clouse, “Hepatic arterial embolization for metastatic hormone-secreting tumors,” Technique, Effectiveness, and Complications, Cancer, vol. 65, no. 10, pp. 2227–2232, 1990. View at Google Scholar
  20. F. Stockmann, H. J. Von Romatowski, W. V. Reimold, R. Schuster, and W. Creutzfeldt, “Hepatic artery embolization for treatment of endocrine gastrointestinal tumors with liver metastases,” Zeitschrift fur Gastroenterologie, vol. 22, no. 11, pp. 652–660, 1984. View at Google Scholar · View at Scopus
  21. S. Gupta, M. M. Johnson, R. Murthy et al., “Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival,” Cancer, vol. 104, no. 8, pp. 1590–1602, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. D. A. Osborne, E. E. Zervos, J. Strosberg et al., “Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors,” Annals of Surgical Oncology, vol. 13, no. 4, pp. 572–581, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. J. A. Ajani, C. H. Carrasco, C. Charnsangavej, N. A. Samaan, B. Levin, and S. Wallace, “Islet cell tumors metastatic to the liver: effective palliation by sequential hepatic artery embolization,” Annals of Internal Medicine, vol. 108, no. 3, pp. 340–344, 1988. View at Google Scholar · View at Scopus
  24. K. T. Brown, B. Y. Koh, L. A. Brody et al., “Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms,” Journal of Vascular and Interventional Radiology, vol. 10, no. 4, pp. 397–403, 1999. View at Google Scholar · View at Scopus
  25. B. K. Eriksson, E. G. Larsson, B. M. Skogseid, A. M. Löfberg, L. E. Lörelius, and K. E. Oberg, “Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors,” Cancer, vol. 83, no. 11, pp. 2293–2301, 1998. View at Google Scholar
  26. T. X. Yang, T. C. Chua, and D. L. Morris, “Radioembolization and chemoembolization for unresectable neuroendocrine liver metastases—a systematic review,” Surgical Oncology, vol. 21, no. 4, pp. 299–308, 2012. View at Google Scholar
  27. K. A. Yao, M. S. Talamonti, A. Nemcek et al., “Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors,” Surgery, vol. 130, no. 4, pp. 677–685, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. L. M. Sutherland, J. A. R. Williams, R. T. A. Padbury, D. C. Gotley, B. Stokes, and G. J. Maddern, “Radiofrequency ablation of liver tumors: a systematic review,” Archives of Surgery, vol. 141, no. 2, pp. 181–190, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Murthy, R. Nunez, J. Szklaruk et al., “Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications,” Radiographics, vol. 25, supplement 1, pp. S41–S55, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Grozinsky-Glasberg, D. Barak, M. Fraenkel et al., “Peptide receptor radioligand therapy is an effective treatment for the long-term stabilization of malignant gastrinomas,” Cancer, vol. 117, no. 7, pp. 1377–1385, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Oberleithner, C. Riethmüller, T. Ludwig et al., “Differential action of steroid hormones on human endothelium,” Journal of Cell Science, vol. 119, no. 9, pp. 1926–1932, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Tombran-Tink, N. Lara, S. E. Apricio et al., “Retinoic acid and dexamethasone regulate the expression of PEDF in retinal and endothelial cells,” Experimental Eye Research, vol. 78, no. 5, pp. 945–955, 2004. View at Publisher · View at Google Scholar · View at Scopus